Contact
LocationResearch & Development, Level 2, Bircham Park, PL6 5FP, Plymouth, Devon
Our experts
Current trials
Completed
Phase iii
PHOENIX trial
Industry trial
Amylyx Pharmaceuticals Inc is conducting a phase 3 trial to determine the safety and efficacy of their compound 'AMX0035' for the treatment of ALS.